N-Acetylcysteine and L-carnitine in Pcos

N-Acetylcysteine Versus L-carnitine in Clomiphene Citrate Resistant Pcos Women. a Randomized Controlled Trial

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03164421

Enrollment

164

Registered

2017-05-23

Start date

2017-01-31

Completion date

2018-07-31

Last updated

2018-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS

Brief summary

N-Acetylcysteine and L-carnitine were used in pcos patients

Detailed description

N-Acetylcysteine was compared to L-carnitine in clomiphene citrate in Pcos women to detect the hormonal and metabolic effect

Interventions

DRUGL-carnitine

L-carnitine in clomiphene resistant pcos women

DRUGN-Acetylcysteine

N-Acetylcysteine in clomiphene resistant pcos women

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* pco * infertile

Exclusion criteria

* no medical disorders * no hormonal treatment in the previous 3 months

Design outcomes

Primary

Measure	Time frame	Description
pregnancy rate	3 momths	number of women with clinical pregnancy

Secondary

Measure	Time frame	Description
ovulation rate	3 momths	number of women with follicle \>18mm.
abortion rate	3 momths	number of women with abortions

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026